Literature DB >> 8246986

Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching.

J M Lehmann1, X K Zhang, G Graupner, M O Lee, T Hermann, B Hoffmann, M Pfahl.   

Abstract

Thyroid hormone receptors (TRs) form heterodimers with retinoid X receptors (RXRs). Heterodimerization is required for efficient TR DNA binding to most response elements and transcriptional activation by thyroid hormone. RXRs also function as auxiliary proteins for several other receptors. In addition, RXR alpha can be induced by specific ligands to form homodimers. Here we report that RXR-specific retinoids that induce RXR homodimers are effective repressors of the T3 response. We provide evidence that this repression by RXR-specific ligands occurs by sequestering of RXR from TR-RXR heterodimers into RXR homodimers. This ligand-induced squelching may represent an important mechanism by which RXR-specific retinoids and 9-cis retinoic acid mediate hormonal cross talk among a subfamily of nuclear receptors activated by structurally unrelated ligands.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246986      PMCID: PMC364841          DOI: 10.1128/mcb.13.12.7698-7707.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

Review 1.  Gene regulation by steroid hormones.

Authors:  M Beato
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

2.  DNA binding and dimerization determinants for thyroid hormone receptor alpha and its interaction with a nuclear protein.

Authors:  X K Zhang; P B Tran; M Pfahl
Journal:  Mol Endocrinol       Date:  1991-12

Review 3.  Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells.

Authors:  R Lotan
Journal:  Biochim Biophys Acta       Date:  1980-03-12

4.  Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem.

Authors:  V Mahdavi; A P Chambers; B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity.

Authors:  G Graupner; K N Wills; M Tzukerman; X K Zhang; M Pfahl
Journal:  Nature       Date:  1989-08-24       Impact factor: 49.962

6.  H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element.

Authors:  K Hamada; S L Gleason; B Z Levi; S Hirschfeld; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  A novel thyroid hormone receptor encoded by a cDNA clone from a human testis library.

Authors:  D Benbrook; M Pfahl
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

Review 8.  Retinoids as preventive and therapeutic anticancer agents (Part I).

Authors:  S M Lippman; J F Kessler; F L Meyskens
Journal:  Cancer Treat Rep       Date:  1987-04

9.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M E Huang; Y C Ye; S R Chen; J R Chai; J X Lu; L Zhoa; L J Gu; Z Y Wang
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

10.  Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin.

Authors:  K H Kraemer; J J DiGiovanna; A N Moshell; R E Tarone; G L Peck
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more
  32 in total

1.  A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics.

Authors:  Bentley J Hanish; Jennifer F Hackney Price; Ichiro Kaneko; Ning Ma; Arjan van der Vaart; Carl E Wagner; Peter W Jurutka; Pamela A Marshall
Journal:  Steroids       Date:  2018-04-26       Impact factor: 2.668

2.  Direct interdomain interactions can mediate allosterism in the thyroid receptor.

Authors:  Balananda-Dhurjati K Putcha; Elias J Fernandez
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

3.  Differential modulation of transcriptional activity of oestrogen receptors by direct protein-protein interactions with retinoid receptors.

Authors:  M R Song; S K Lee; Y W Seo; H S Choi; J W Lee; M O Lee
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

4.  DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita.

Authors:  M Ito; R Yu; J L Jameson
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  High level transactivation by the ecdysone receptor complex at the core recognition motif.

Authors:  M Vögtli; C Elke; M O Imhof; M Lezzi
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

6.  Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces.

Authors:  J G Savory; G G Préfontaine; C Lamprecht; M Liao; R F Walther; Y A Lefebvre; R J Haché
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

7.  Single thyroid hormone receptor monomers are competent for co-activator-mediated transactivation.

Authors:  M Quack; C Carlberg
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

8.  Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor.

Authors:  X K Zhang; G Salbert; M O Lee; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers.

Authors:  B Cheskis; L P Freedman
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha.

Authors:  F X Claret; T Antakly; M Karin; F Saatcioglu
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.